These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 29325270)

  • 21. Expression of alpha 6 and beta 4 integrins in serous ovarian carcinoma correlates with expression of the basement membrane protein laminin.
    Skubitz AP; Bast RC; Wayner EA; Letourneau PC; Wilke MS
    Am J Pathol; 1996 May; 148(5):1445-61. PubMed ID: 8623916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of epithelial cell adhesion molecule in primary, metastatic, and recurrent/chemotherapy-resistant epithelial ovarian cancer: implications for epithelial cell adhesion molecule-specific immunotherapy.
    Bellone S; Siegel ER; Cocco E; Cargnelutti M; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
    Int J Gynecol Cancer; 2009 Jul; 19(5):860-6. PubMed ID: 19574774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The comparison of biological characteristics between tumor-infiltrating lymphocytes and tumor-associated lymphocytes in ascites of epithelial ovarian carcinoma].
    Kang S; Shen K; Lang J
    Zhonghua Fu Chan Ke Za Zhi; 1998 Oct; 33(10):607-10. PubMed ID: 10806687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Isolation, identification and clinical significance of ascites-derived exosomes from patients with ovarian epithelial cancer].
    Peng P; You Y; Shen K
    Zhonghua Fu Chan Ke Za Zhi; 2009 Apr; 44(4):268-72. PubMed ID: 19570464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Significance of concentration of serum soluble vascular cell adhesion molecule-1 in epithelial ovarian carcinoma].
    Qiao XM; Wang ZM
    Ai Zheng; 2004 Jan; 23(1):81-4. PubMed ID: 14720381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
    Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
    Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High levels of circulating CD34+/VEGFR3+ lymphatic/vascular endothelial progenitor cells is correlated with lymph node metastasis in patients with epithelial ovarian cancer.
    Qiu H; Cao L; Wang D; Xu H; Liang Z
    J Obstet Gynaecol Res; 2013 Jul; 39(7):1268-75. PubMed ID: 23803010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Expression and significance of tumor suppressor gene WAF1 in epithelial ovarian neoplasms].
    Cao L; Yang Z; Li X
    Hunan Yi Ke Da Xue Xue Bao; 1998; 23(6):602-4. PubMed ID: 10806783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Expression and significance of p-AKT, p-GSK3β and β-catenin in epithelial carcinoma of ovary].
    Wei X; Lü QJ; Sun HX; Qi YF; Wang JO; Cao CC
    Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):86-90. PubMed ID: 22455883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cdc7 kinase is a predictor of survival and a novel therapeutic target in epithelial ovarian carcinoma.
    Kulkarni AA; Kingsbury SR; Tudzarova S; Hong HK; Loddo M; Rashid M; Rodriguez-Acebes S; Prevost AT; Ledermann JA; Stoeber K; Williams GH
    Clin Cancer Res; 2009 Apr; 15(7):2417-25. PubMed ID: 19318489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ovarian yolk sac tumors in older women arising from epithelial ovarian tumors or with no detectable epithelial component.
    Roth LM; Talerman A; Levy T; Sukmanov O; Czernobilsky B
    Int J Gynecol Pathol; 2011 Sep; 30(5):442-51. PubMed ID: 21804392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epithelial metaplastic changes in ovarian endometriosis.
    Fukunaga M; Ushigome S
    Mod Pathol; 1998 Aug; 11(8):784-8. PubMed ID: 9720509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differentiation of epithelial ovarian cancer subtypes by use of imaging and clinical data: a detailed analysis.
    Tanaka YO; Okada S; Satoh T; Matsumoto K; Oki A; Saida T; Yoshikawa H; Minami M
    Cancer Imaging; 2016 Feb; 16():3. PubMed ID: 26873307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinct expression and localization of TNF system in ovarian carcinoma tissues: possible involvement of TNF-α in morphological changes of ovarian cancerous cells.
    Piura B; Medina L; Rabinovich A; Dyomin V; Levy RS; Huleihel M
    Anticancer Res; 2014 Feb; 34(2):745-52. PubMed ID: 24511008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating tumour markers in ovarian tumours.
    von Schlippe M; Rustin GJ
    Forum (Genova); 2000; 10(4):383-92. PubMed ID: 11535987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Primary ovarian malignant mixed mesodermal tumor (MMMT) as a second primary tumor in a patient with invasive breast carcinoma--case report].
    Sentija K; Bolanca IK; Simon SK; Kukura V; Skrtić A; Gasparov S
    Acta Med Croatica; 2011 Sep; 65 Suppl 1():229-34. PubMed ID: 23126058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Erythropoietin receptor function and expression in epithelial ovarian carcinoma.
    McBroom JW; Acs G; Rose GS; Krivak TC; Mohyeldin A; Verma A
    Gynecol Oncol; 2005 Dec; 99(3):571-7. PubMed ID: 16051335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma.
    Gilks CB; Ionescu DN; Kalloger SE; Köbel M; Irving J; Clarke B; Santos J; Le N; Moravan V; Swenerton K;
    Hum Pathol; 2008 Aug; 39(8):1239-51. PubMed ID: 18602670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum follicle-stimulating hormone and risk of epithelial ovarian cancer in postmenopausal women.
    Arslan AA; Zeleniuch-Jacquotte A; Lundin E; Micheli A; Lukanova A; Afanasyeva Y; Lenner P; Krogh V; Muti P; Rinaldi S; Kaaks R; Berrino F; Hallmans G; Toniolo P
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1531-5. PubMed ID: 14693749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequent down-regulation and lack of mutation of the KAI1 metastasis suppressor gene in epithelial ovarian carcinoma.
    Liu FS; Dong JT; Chen JT; Hsieh YT; Ho ES; Hung MJ
    Gynecol Oncol; 2000 Jul; 78(1):10-5. PubMed ID: 10873402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.